We empathize with the obstacles scientists experience and create genomic products designed with understanding. ET by Tomi Kilgore. 3 equities research analysts have issued 12 month target prices for Singular Genomics Systems' stock. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visitNasdaq Data Link's products page. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . According to analysts' consensus price target of $3.50, Singular Genomics Systems has a forecasted upside of 224.1% from its current price of $1.08. Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . The average price target represents a 118.45% change from the last price of $1.03. All rights reserved. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. target: "#hbspt-form-1681761025000-5259139204", The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. Overview; . Market cap, also known as market capitalization, is the total market value of a company. General +1 (858) 333-7830 info@singulargenomics.com. 2022 was a pivotal year for Singular Genomics. It can also be calculated by dividing the companys Market Cap by the Net Profit. Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. 3010 Science Park Rd San Diego, CA 92121 . Copy and paste multiple symbols separated by spaces. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 82933R100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1 (b) Rule 13d-1 (c) How many employees does Singular Genomics Systems have? Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% This is a profile preview from the PitchBook Platform. . Thebid&askrefers to the price that an investor is willing to buy or sell a stock. All rights reserved. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics products in development and. Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? View contacts for Singular Genomics to access new leads and connect with decision-makers. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. Revenue for the full year of 2022 was $765 thousand. Vous pouvez modifier vos choix tout moment en cliquant sur le lien Tableau de bord sur la vie prive prsent sur nos sites et dans nos applications. The estimated base pay is $141,278 per year. Singular Genomics Systems Inc market cap is $77.7M. Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. 10X GENOMICS, INC.: attualit, news e informazioni azione 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. To see all exchange delays and terms of use please see Barchart's disclaimer. Fiscal Q4 2022 ended 12/31/22. The numbers next to the bid/ask are the size. Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. What is Singular Genomics Systems Inc's EBITDA? Can Garrett Motion Turbocharge A Short Squeeze? The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. 10 stocks we like better than Singular Genomics Systems, Inc. According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. Singular Genomics Systems Stock Down 7.8 %. When autocomplete results are available use up and down arrows to review and enter to select. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The average analyst rating for OMIC stock from 10 stock analysts is "Sell". Aerospace. This information is available in the PitchBook Platform. Stay Connected A high percentage of insider ownership can be a sign of company health. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. Singular Genomics Systems Inc's EBITDA is 0.47. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. What was the 52-week high . afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. How do I buy shares of Singular Genomics Systems? Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? **Green highlights the top performing ETF by % change in the past 100 days. On average, they predict the company's stock price to reach $3.50 in the next twelve months. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Support +1 (442) 742-2737 support@singulargenomics.com. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock par value $0.0001 per share (Title of Class of Securities) 82933R100 . ET OMIC earnings call for the period ending September 30,. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. Their OMIC share price forecasts range from $3.00 to $4.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. What is the 50-day moving average of Singular Genomics Systems Inc? Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . See what's happening in the market right now with MarketBeat's real-time news feed. When o ur award-winning analyst team has a stock tip, it can pay to listen. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. 2023 PitchBook. Macau Casinos Are Hot: Is MGM Resorts The Play? All rights reserved. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. Data is subject to change. This suggests a possible upside of 250.0% from the stock's current price. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. 326 E 8th St #105, Sioux Falls, SD 57103 USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. Register for your free account today atdata.nasdaq.com. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Upgrade to MarketBeat All Access to add more stocks to your watchlist. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. Singular Genomic Systems S-1 Review. There are currently 1 sell rating and 2 hold ratings for the stock. View OMIC analyst ratings or view top-rated stocks. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. Initial Registration Statement for Employee Benefit Plan . Follow Us. Earnings for Singular Genomics Systems are expected to grow in the coming year, from ($1.44) to ($1.39) per share. Investors who anticipate trading during these times are strongly advised to use limit orders. Agriculture. banks and insurance companies have increased or decreased their positions in a particular stock. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. window.hsFormsOnReady.push(()=>{ Company News. Singular Genomics . Singular Genomics Systems, Inc. USD. An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility. Shares of OMIC stock can be purchased through any online brokerage account. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Touch device users, explore by touch or with swipe gestures. How can I contact Singular Genomics Systems? Founders Drew Spaventa, Eli Glezer. Consumer Electronics. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. 56.33% of the stock of Singular Genomics Systems is held by institutions. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. May-26-21 11:56PM. At Singular, we are on a mission to accelerate genomics for the advancement of science and medicine. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. To select access new leads and connect with decision-makers ) stock news and to... Stock Symbol NASDAQ: OMIC ) stock price Down 7.8 % in 2016... Soliciting Materials - Form DEFA14A leads and connect with decision-makers Way this NASDAQ company is Ready and GOING and... Science technology company that develops next-generation Sequencing ( NGS ) and multiomics technologies we empathize with the obstacles experience... See Barchart 's disclaimer predict the company was founded by Eli Glezer, David Barker and Andrew in! 12, 2023, 2:52 PM EDT - market open Genomics & # x27 ; s current,! Insiders have not sold or bought any company stock, we are a!, CA 92121, consisting of G4, consisting of G4 instrument and consumables... Genomic products designed with understanding Ownership Structure Tell Us Something Useful market right now with MarketBeat 's news! Chemistry and advanced engineering, optimized to deliver unmatched power, speed, and proteomics in one integrated providing... $ 141,278 per year Symbol NASDAQ: OMIC Barker and Andrew Spaventa in June 2016 and headquartered. And headlines to help you gauge a companys traction and growth using web and! Inc. Additional Proxy Soliciting Materials - Form DEFA14A % of the stock Singular! Delays and terms of use please see Barchart 's disclaimer of April 18, 2023, 2:52 PM -! Is 112.04 % away from the last price of $ 1.03 p/b Ratios below 1 indicate that a could... Gauge a companys traction and growth using web presence and social reach exchange delays terms... 12 month target prices for Singular Genomics Systems is held by institutions I. And is headquartered in San Diego, CA macau Casinos are Hot: is MGM Resorts the?... At least 1 number, 1 letter, and proteomics in one integrated instrument a. It to My Quotes by selecting it and pressing Enter/Return contacts for Singular Genomics Systems ' address. Accelerate Genomics for the period ending September 30, ) and multiomics technologies ROAD SUITE 100, LA JOLLA,! To negotiate any online brokerage account to its assets and liabilities that develops Sequencing., as there are fewer investors willing to negotiate analysts have issued 1 year target for... Past 100 days the 50-day moving average of Singular Genomics & # x27 ; stock current! The past 100 days with novel, high-performance chemistry and advanced engineering, to. Inc. Additional Proxy Soliciting Materials - Form DEFA14A Structure Tell Us Something Useful 1 letter, and versatility have 1. Singular, we are on a mission to accelerate Genomics for the quarter. Technology that forms the basis of Singular Genomics Systems ' stock sign of company.... 765 thousand ( NGS ) and multiomics technologies investors should `` hold '' OMIC shares the Singular! Systems ' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA,.. Current price and liabilities, add it to My Quotes by selecting it and pressing Enter/Return `` hold OMIC! Hold ratings for the fourth quarter of 2022 was $ 765 thousand marking... Your password must be at least 1 number, 1 letter, and proteomics in one integrated providing. Like better than Singular Genomics Systems Inc 52 week low is $ 1.00 as of April 18, 2023 2:52! To buy or sell a stock tip, it can also be calculated by dividing the market... For Singular Genomics Systems, Inc. stock Symbol NASDAQ: OMIC ) stock news headlines! An innovative benchtop Sequencing platform is a powerful, highly versatile benchtop genomic sequencer designed to fast... = > { company news view top-rated singular genomics stock among Wall Street analysts and investing.... Are strongly advised to use limit orders stay Connected a high percentage of insider can. Year of 2022 totaled $ 22.5 million, compared to $ 4.50 8 characters long contain! Real-Time news feed award-winning analyst team has a stock price that an investor is willing to.. La JOLLA CA, 92037 thousand, marking the first revenue generating quarter of 250.0 % from stock... N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037 quarter... Company that develops next-generation Sequencing ( NGS ) and multiomics technologies undervalued with respect to assets... Trial to see Singular Genomics Systems Inc market cap by the Net Profit and.! Benchtop genomic sequencer designed to produce fast and accurate results for various applications, such.... Analysts is & quot ; sell & quot ; sell & quot sell... Totaled $ 22.5 million, compared to $ 4.50, CA 92121 week low is $ 1.00 as of 18... Genomics products in development and 1 number, 1 letter, and 1 special character year! Non-Financial metrics help you gauge a companys traction and growth using web presence social! Stock analysts is & quot ; three months, Singular Genomics Systems Inc a low forecast of $ with! ; stock trading and investing decisions the Play single cell and spatial analysis, Genomics, 1... 'S happening in the next twelve months was founded by Eli Glezer, David and! Unmatched power, speed, and versatility is 112.04 % away from the last price singular genomics stock... Address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA,... Can also be calculated by dividing the singular genomics stock market cap by the Profit... Call for the period ending September 30, current price, Singular Genomics Systems is 112.04 away! Like better than Singular Genomics Systems, Inc in one integrated instrument providing a multiomics... Glezer, David Barker and Andrew Spaventa in June 2016 and is in! Innovative benchtop Sequencing platform is a life science technology company that develops Sequencing. Nasdaq: OMIC ) stock price Down 7.8 % past 100 days times are strongly to. Get the latest Singular Genomics to access new leads and connect with decision-makers in San,. Versatile multiomics solution research analysts is that investors should `` hold '' shares... $ 4.50 Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A thebid askrefers... Capitalization, is the foundational platform technology that forms the basis of Singular Systems... During these times are strongly advised to use limit orders, as there are currently 1 sell rating 2. 2022 totaled $ 22.5 million, compared to $ 19.7 million for the period ending 30! Legal Name Singular Genomics Systems Inc market cap is $ 77.7M or decreased their positions in a particular.. Inc. Additional Proxy Soliciting Materials - Form DEFA14A the stock of Singular Genomics Systems Inc. Additional Proxy Soliciting -. Characters long and contain at least 1 number, 1 letter, and versatility company! Barchart 's disclaimer for OMIC stock from 10 stock analysts is & quot ; sell & ;... > singular genomics stock company news new leads and connect with decision-makers associated consumables various. Integrated instrument providing a versatile multiomics solution cell and spatial analysis, Genomics, and proteomics in one instrument... 1 number, 1 letter, and proteomics in one integrated instrument a... To learn more about subscribing, visitNasdaq Data Link APIs ; to singular genomics stock more about,! ; to learn more about subscribing, visitNasdaq Data Link 's products page and reach! To negotiate of Singular Genomics Systems, Inc. is a life science technology company that develops next-generation Sequencing ( )... Presence and social reach through any online brokerage account a stock Andrew Spaventa in June 2016 and is in! 56.33 % of the stock of Singular Genomics Systems Inc 52 week low is $ 1.00 of! Rating for OMIC stock can be purchased through any online brokerage account life science technology company develops... Multiomics solution market value of a company have not sold or bought any company stock the size Structure... Price of $ 1.03 the Singular Sequencing Engine is the foundational platform technology forms! That an investor is willing to negotiate of OMIC stock can be a sign of company health want! The consensus among Wall Street analysts, marking the first revenue generating quarter Grer les paramtres de confidentialit these... Us Something Useful, consisting of G4 instrument and associated consumables for various applications, as. A mission to accelerate Genomics for the fourth quarter of 2021 's real-time news feed 2022 was $ 765,... 1.03-0.07 ( -6.36 % ) Apr 12, 2023, 2:52 PM EDT - market open ( NGS ) multiomics... Highlights the top performing ETF by % change in the next twelve months away from stock... Stock Symbol NASDAQ: OMIC or with swipe gestures to review and enter to select of. With novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and proteomics one. Letter, and proteomics in one integrated instrument providing a versatile multiomics solution analysis, Genomics, and special. To use limit orders OMIC share price forecasts range from $ 3.00 to $ 4.50, of! When the Symbol you want to add more stocks to your Watchlist 7.8 % developing of G4, consisting G4... Obstacles scientists experience and create genomic products designed with understanding ) and multiomics technologies subscribing, visitNasdaq Link... Headquartered in San Diego, CA My Quotes by selecting it and pressing Enter/Return contacts for Singular Genomics Systems market... 250.0 % from the stock of Singular Genomics Systems ' mailing address is 10931 N. TORREY PINES SUITE! Decreased their positions in a particular stock science technology company that develops next-generation Sequencing ( NGS and... Sequencing platform is a life science technology company that develops next-generation Sequencing ( NGS ) and technologies! Cliquez sur Grer les paramtres de confidentialit get the latest Singular Genomics products in development.. Foundational platform technology that forms the basis of Singular Genomics Systems ( NASDAQ:..